Cresud S.A.C.I.F. y A. CRESY
12.71
(0.03)
(0.24%)
as of 25 Sep
- Market cap
- $903.7M
- P/E
- 5.4×
Follow CRESY
Insider Buys
alert about insiders buying in the last 12 month
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
5.37 | 3.77 | 3.40 | 7.14 |
+8 more quarters Free account |
P/S ratio |
0.90 | 0.87 | 0.59 | 0.69 | |
P/FCF ratio |
4.92 | 3.34 | 2.33 | 4.80 | |
P/Operating CF |
(22.06) | (14.98) | 4.50 | 4.19 | |
P/B ratio |
0.41 | 0.43 | 0.27 | 0.28 | |
Price to Tangible BV |
0.42 | 0.44 | 0.27 | 0.29 | |
EV/Sales |
1.37 | 1.34 | 0.93 | 1.04 | |
EV/EBITDA |
3.51 | 2.10 | 1.33 | 4.01 | |
EV/Operating CF |
6.85 | 5.03 | 3.52 | 6.29 | |
EV/FCF |
7.52 | 5.15 | 3.63 | 7.28 | |
Quick Ratio |
1.05 | 1.07 | 1.01 | 0.93 | |
Current Ratio |
1.43 | 1.43 | 1.33 | 1.24 | |
Net Debt/EBITDA |
(5.23) | 23.89 | 1.41 | 1.59 | |
Debt/Assets |
19.78% | 21.29% | 17.37% | 15.87% | |
Debt/Equity |
0.46 | 0.52 | 0.40 | 0.36 | |
Asset Turnover |
0.21 | 0.21 | 0.21 | 0.15 | |
Operating CF/Net income |
(1.31) | (2.17) | 4.12 | 1.87 | |
Capex/Depreciation |
(4.07) | 2.69 | 0.84 | (1.52) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
27.51% | 20.22% | 18.41% | 27.95% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(1.78) | (1.88) | (2.77) | (2.59) | |
Graham Number |
40.51 | 46.89 | 44.40 | 34.99 | |
Earnings Yield |
18.63% | 26.52% | 29.40% | 14.00% | |
Free Cash Flow Yield |
20.33% | 29.96% | 42.85% | 20.83% | |
Revenue per Share |
2.76 | 3.44 | 4.19 | 4.36 | |
Operating CF per Share |
(0.58) | (0.84) | 2.00 | 2.51 | |
Capex per Share |
(0.29) | 0.14 | 0.05 | (0.16) | |
Free Cash Flow per Share |
(0.87) | (0.70) | 2.04 | 2.35 | |
Cash per Share |
7.35 | 8.19 | 8.33 | 8.09 | |
Shareholders Equity per Share |
30.77 | 29.17 | 33.19 | 37.02 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.77 | 29.17 | 33.19 | 37.02 | |
Free Cash Flow |
(55.73) | (43.67) | 124.46 | 140.54 | |
Working Capital |
342.41 | 331.92 | 282.35 | 244.92 | |
Capital Expenditures |
(18.81) | 9.07 | 2.89 | (9.31) | |
Net Current Asset Value |
(1,450.19) | (1,487.97) | (1,514.83) | (1,628.33) | |
EV/EBIT |
3.69 | 2.16 | 1.37 | 4.31 | |
Capex to Sales |
0.11 | (0.04) | (0.01) | 0.04 | |
Net Profit Margin |
15.90% | 11.29% | 11.57% | 30.79% | |
Price to Operating Income |
2.41 | 1.40 | 0.88 | 2.84 | |
| Other line items | |||||
Average Receivables |
347.03 | 339.34 | 358.99 | 485.99 | |
Average Payables |
277.14 | 321.75 | 325.67 | 413.75 | |
Average Inventory |
278.59 | 256.49 | 233.62 | 334.37 | |
Average Assets |
4,357.43 | 4,387.16 | 4,370.36 | 6,017.52 | |
Average Common Equity |
1,841.14 | 1,825.36 | 1,923.16 | 2,670.80 |
Columns are period end dates